Margaret Kyle - Publications, H-index & Citations

Margaret Kyle

Universite PSL

27H指数

106论文数

2.3K被引数

收录论文 9

发表时间

TRIPS, pharmaceutical patents, and generic competition in India TRIPS、药品专利和印度仿制药竞争

Health Affairs Scholar

IF0

2026-02-01

OAAI

Kyle, Margaret K.; Sampat, Bhaven N.; Shadlen, Kenneth C.

THE MORE WE DIE, THE MORE WE SELL? A SIMPLE TEST OF THE HOME-MARKET EFFECT

QUARTERLY JOURNAL OF ECONOMICS

IF12.7

2019-01-21

OAAI

Costinot, Arnaud; Donaldson, Dave; Kyle, Margaret; Williams, Heidi

Is American Health Care Uniquely Inefficient? Evidence from Prescription Drugs

AMERICAN ECONOMIC REVIEW

IF11.6

2017-05-01

OAAI

Kyle, Margaret; Williams, Heidi

INVESTMENTS IN PHARMACEUTICALS BEFORE AND AFTER TRIPS

REVIEW OF ECONOMICS AND STATISTICS

IF6.8

2012-11-01

OAAI

Kyle, Margaret K.; McGahan, Anita M.

Evolving Brand-Name And Generic Drug Competition May Warrant A Revision Of The Hatch-Waxman Act

HEALTH AFFAIRS

IF8.1

2011-11-01

OAAI

Grabowski, Henry G.; Kyle, Margaret; Mortimer, Richard; Long, Genia; Kirson, Noam

Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets

GLOBALIZATION AND HEALTH

IF4.5

2010-01-01

OAAI

Waning, Brenda; Kyle, Margaret; Diedrichsen, Ellen; Soucy, Lyne; Hochstadt, Jenny; Baernighausen, Till; Moon, Suerie

Does reimportation reduce price differences for prescription drugs? Lessons from the European Union

HEALTH SERVICES RESEARCH

IF3.2

2008-07-16

OAAI

Kyle, Margaret K.; Allsbrook, Jennifer S.; Schulman, Kevin A.

Would greater transparency and uniformity of health care prices benefit poor patients?

HEALTH AFFAIRS

IF8.1

2007-09-01

OAAI

Kyle, Margaret K.; Ridley, David B.

Pharmaceutical price controls and entry strategies

REVIEW OF ECONOMICS AND STATISTICS

IF6.8

2007-02-01

146

OAAI

Kyle, Margaret K.

研究方向